Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial
Background and objective: There are barriers to providing pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) such as the high number of patients, difficult access to health facilities and high costs of programs. Pedometers can monitor and improve physical activity (PA). The ai...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2018-07-01
|
Series: | Pulmonology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531043718300382 |
id |
doaj-2802b610a528446d9de9301947c11085 |
---|---|
record_format |
Article |
spelling |
doaj-2802b610a528446d9de9301947c110852020-11-25T03:46:37ZengElsevier EspañaPulmonology2531-04372018-07-01244211218Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trialK. Widyastuti0D.N. Makhabah1A.Rima Setijadi2Y.S. Sutanto3 Suradi4N. Ambrosino5Pulmonology Department, Medical Faculty, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central Jawa, Indonesia; Corresponding author.Pulmonology Department, Medical Faculty, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central Jawa, IndonesiaPulmonology Department, Medical Faculty, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central Jawa, IndonesiaPulmonology Department, Medical Faculty, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central Jawa, IndonesiaPulmonology Department, Medical Faculty, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central Jawa, IndonesiaIstituti Clinici Scientifici Maugeri: Scientific Institute, IRCCS, Montescano, ItalyBackground and objective: There are barriers to providing pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) such as the high number of patients, difficult access to health facilities and high costs of programs. Pedometers can monitor and improve physical activity (PA). The aim of this study was to evaluate benefits and costs of home pedometer assisted PA, as compared to a standard outpatient supervised exercise training program in patients with COPD. Methods: Patients were randomly assigned either to home pedometer assisted PA (Group 1), or to a six-week outpatient standard supervised exercise training program (Group 2). Patients of Group 1 had to walk at home for 6 weeks, at least 30 min daily at the fastest step pace as possible, to achieve a weekly 10% increase in their average daily steps up to more than 6500. Pre and post programs we assessed: the six minute walking distance (6MWT: primary outcome), daily steps count, the Medical Research Council scale (MRC), the COPD assessment test score, and the BODE index (body-mass index, airflow obstruction, dyspnea, exercise capacity). Costs of programs were also evaluated. Results: Out of 40 patients, 18 in both groups (mean (standard deviation)) age: 68.3 (6.7) and 61.2 (6.7) years; FEV1: 1.1 (0.5) and 0.9 (0.4) liters in Group 1 and 2 respectively completed the study. At the end of the program 44.5% patients of Group 1 had reached the target daily steps, in 26.6 (9.5) days. Following the programs, both groups showed significant improvements in all outcome measures, except BODE. The home program was cheaper (p = 0.0001), with a mean 76.3 euros saving per patient. Conclusion: Home pedometer assisted PA may be a useful and cheaper alternative to outpatient supervised exercise training programs in patients with COPD. Keywords: Exercise training, Dyspnea, Quality of life, Exercise tolerance, Physical activityhttp://www.sciencedirect.com/science/article/pii/S2531043718300382 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
K. Widyastuti D.N. Makhabah A.Rima Setijadi Y.S. Sutanto Suradi N. Ambrosino |
spellingShingle |
K. Widyastuti D.N. Makhabah A.Rima Setijadi Y.S. Sutanto Suradi N. Ambrosino Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial Pulmonology |
author_facet |
K. Widyastuti D.N. Makhabah A.Rima Setijadi Y.S. Sutanto Suradi N. Ambrosino |
author_sort |
K. Widyastuti |
title |
Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial |
title_short |
Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial |
title_full |
Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial |
title_fullStr |
Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial |
title_full_unstemmed |
Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial |
title_sort |
benefits and costs of home pedometer assisted physical activity in patients with copd. a preliminary randomized controlled trial |
publisher |
Elsevier España |
series |
Pulmonology |
issn |
2531-0437 |
publishDate |
2018-07-01 |
description |
Background and objective: There are barriers to providing pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) such as the high number of patients, difficult access to health facilities and high costs of programs. Pedometers can monitor and improve physical activity (PA). The aim of this study was to evaluate benefits and costs of home pedometer assisted PA, as compared to a standard outpatient supervised exercise training program in patients with COPD. Methods: Patients were randomly assigned either to home pedometer assisted PA (Group 1), or to a six-week outpatient standard supervised exercise training program (Group 2). Patients of Group 1 had to walk at home for 6 weeks, at least 30 min daily at the fastest step pace as possible, to achieve a weekly 10% increase in their average daily steps up to more than 6500. Pre and post programs we assessed: the six minute walking distance (6MWT: primary outcome), daily steps count, the Medical Research Council scale (MRC), the COPD assessment test score, and the BODE index (body-mass index, airflow obstruction, dyspnea, exercise capacity). Costs of programs were also evaluated. Results: Out of 40 patients, 18 in both groups (mean (standard deviation)) age: 68.3 (6.7) and 61.2 (6.7) years; FEV1: 1.1 (0.5) and 0.9 (0.4) liters in Group 1 and 2 respectively completed the study. At the end of the program 44.5% patients of Group 1 had reached the target daily steps, in 26.6 (9.5) days. Following the programs, both groups showed significant improvements in all outcome measures, except BODE. The home program was cheaper (p = 0.0001), with a mean 76.3 euros saving per patient. Conclusion: Home pedometer assisted PA may be a useful and cheaper alternative to outpatient supervised exercise training programs in patients with COPD. Keywords: Exercise training, Dyspnea, Quality of life, Exercise tolerance, Physical activity |
url |
http://www.sciencedirect.com/science/article/pii/S2531043718300382 |
work_keys_str_mv |
AT kwidyastuti benefitsandcostsofhomepedometerassistedphysicalactivityinpatientswithcopdapreliminaryrandomizedcontrolledtrial AT dnmakhabah benefitsandcostsofhomepedometerassistedphysicalactivityinpatientswithcopdapreliminaryrandomizedcontrolledtrial AT arimasetijadi benefitsandcostsofhomepedometerassistedphysicalactivityinpatientswithcopdapreliminaryrandomizedcontrolledtrial AT yssutanto benefitsandcostsofhomepedometerassistedphysicalactivityinpatientswithcopdapreliminaryrandomizedcontrolledtrial AT suradi benefitsandcostsofhomepedometerassistedphysicalactivityinpatientswithcopdapreliminaryrandomizedcontrolledtrial AT nambrosino benefitsandcostsofhomepedometerassistedphysicalactivityinpatientswithcopdapreliminaryrandomizedcontrolledtrial |
_version_ |
1724505390235779072 |